期刊文献+

肠道菌群和黏膜免疫与心血管疾病关系研究新进展 被引量:13

New advances in interaction between intestinal flora and mucosal immunity on development of cardiovascular diseases
下载PDF
导出
摘要 心血管病是目前导致死亡的主要原因之一。引起心血管疾病的主要发生机制是免疫性炎症。肠道菌群与黏膜免疫相互作用,同心血管系统生理功能维持和疾病发生关系密切。肠道菌群失调会导致血管炎、高血压和动脉粥样硬化的发生及心衰的加重。深入了解肠道菌群、黏膜免疫和心血管疾病之间的相互作用机制,可为心血管疾病防治开创新思路。 Cardiovascular disease is one of the leading causes of death.The main mechanism that underline cardiovascular disease is immune inflammation.The interaction between the intestinal flora and the local mucosal immune system is closely related to the maintenance of physiological functions of the cardiovascular system and the occurrence of cardiovascular diseases.Dysregulation of microbiota could lead to the development of vasculitis,hypertension,atherosclerosis and the worsening of heart failure.An in-depth understanding of the interaction mechanism between intestinal flora and mucosal immunity on the development of cardiovascular diseases can open novel pathways for the prevention and treatment of cardiovascular diseases.
作者 赵乐恒 吕昌龙 孙洪涛 ZHAO Le-Heng;L Chang-Long;SUN Hong-Tao(The First Hospital of Inner Mongolia University for Nationalities,Tongliao 028000,China)
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2018年第9期1433-1436,1441,共5页 Chinese Journal of Immunology
基金 内蒙古民族大学特色交叉学科建设项目(MDXK007)资助
关键词 肠道菌群 黏膜免疫 心血管疾病 Intestinal flora Mucosal immunity Cardiovascular diseases
  • 相关文献

参考文献3

二级参考文献34

  • 1刘民,马华,李柏青.MTT法检测小鼠淋巴细胞增殖性反应探讨[J].中国实验动物学杂志,1999,9(3):146-149. 被引量:63
  • 2马亚萍,白剑英.MTT法探讨N-乙酰半胱氨酸对Na_2SO_3小鼠脾淋巴细胞毒性的影响[J].山西医科大学学报,2006,37(10):1020-1021. 被引量:7
  • 3Araya M, Morelli L, Reid G, et al. Guidelines for the evalua- tion of probiotics in food[R]. 2002.
  • 4Vanderhoof JA, Young R. Probioties in the United States [J]. Clinical Infectious Diseases, 2008, 46 (Supplement 2) : $67-72.
  • 5NGGAM. Oral Probiotics An Introduetion[EB/OL]. http:// necanx nih. gov/health/probiotics/introduetion. Htm,2014-01.
  • 6Degnan FH. The US Food and Drug Administration and pro- biotics: regulatory categorization [J]. Clin Infect Dis, 2008, 46(Supplement 2) :$133-$136.
  • 7Amagase H. Current marketplace for probioties: a Japaneseperspeetive[J]. Clin Infect Dis, 2008, 46 (Supplement 2): $73-75.
  • 8中华人民共和国人力资源和社会保障部.2012年最新药品医保目录[EB/OL].http://www.molss.gov.cn/gb/zt/yprnl/ypml.htm,2014-06.
  • 9Guarner F, Khan AG, Garisch J, etal. World gastroenterolo- gy organisation global guidelines: probiotics and prebiotics oc- tober 2011[J]. J Clin Gastroenterol, 2012, 46(6): 468-481.
  • 10Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic anal- ysis for 2010 with time trends since 2000[J]. The Lancet, 2012, 379(9832): 2151-2161.

共引文献77

同被引文献135

引证文献13

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部